Discrete macular cell layers correlated with visual sensitivity loss

Article

Macular inner retinal layer (mIRL) is linked to visual sensitivity in glaucoma patients

Macular inner retinal layer (mIRL) is linked to visual sensitivity in glaucoma patients, according to a study featured in Eye.

A team led by Dr T. S. Varjaranant, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Illinois, USA, compared the thickness of discrete macular cell layers, the thickness of the retinal nerve fibre layer (mRNFL) and visual field sensitivity between 28 glaucoma patients and 22 control patients. Stratus optical coherence tomography macular scans were used to measure thickness of macular retinal nerve fibre layer (mRNFL), macular inner retinal layer (mIRL) and macular outer retinal layer (mORL). Visual sensitivity loss was calculated by mean deviation (MD) using Humphrey Visual Field Analyser. To evaluate structure–function, a mixed model analysis was used.

The findings demonstrated that the mean mIRL thickness was significantly lower in advanced glaucoma than in the control group. Mean mIRL thickness was strongly linked to MD. There were no significant results recorded between mean mORL thickness in early and advanced glaucoma and the control group.

Although there was no difference in macular structure–function between advanced and early glaucoma, both glaucoma groups showed that mIRL thickness was related to visual sensitivity loss.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.